225 related articles for article (PubMed ID: 28440748)
1. Palmitoylated SCP1 is targeted to the plasma membrane and negatively regulates angiogenesis.
Liao P; Wang W; Li Y; Wang R; Jin J; Pang W; Chen Y; Shen M; Wang X; Jiang D; Pang J; Liu M; Lin X; Feng XH; Wang P; Ge X
Elife; 2017 Mar; 6():. PubMed ID: 28440748
[TBL] [Abstract][Full Text] [Related]
2. SCP1 regulates c-Myc stability and functions through dephosphorylating c-Myc Ser62.
Wang W; Liao P; Shen M; Chen T; Chen Y; Li Y; Lin X; Ge X; Wang P
Oncogene; 2016 Jan; 35(4):491-500. PubMed ID: 25893300
[TBL] [Abstract][Full Text] [Related]
3. The Small C-terminal Domain Phosphatase 1 Inhibits Cancer Cell Migration and Invasion by Dephosphorylating Ser(P)68-Twist1 to Accelerate Twist1 Protein Degradation.
Sun T; Fu J; Shen T; Lin X; Liao L; Feng XH; Xu J
J Biol Chem; 2016 May; 291(22):11518-28. PubMed ID: 26975371
[TBL] [Abstract][Full Text] [Related]
4. Phosphatase activity of small C-terminal domain phosphatase 1 (SCP1) controls the stability of the key neuronal regulator RE1-silencing transcription factor (REST).
Burkholder NT; Mayfield JE; Yu X; Irani S; Arce DK; Jiang F; Matthews WL; Xue Y; Zhang YJ
J Biol Chem; 2018 Oct; 293(43):16851-16861. PubMed ID: 30217818
[TBL] [Abstract][Full Text] [Related]
5. Determinants for dephosphorylation of the RNA polymerase II C-terminal domain by Scp1.
Zhang Y; Kim Y; Genoud N; Gao J; Kelly JW; Pfaff SL; Gill GN; Dixon JE; Noel JP
Mol Cell; 2006 Dec; 24(5):759-770. PubMed ID: 17157258
[TBL] [Abstract][Full Text] [Related]
6. A study of substrate specificity for a CTD phosphatase, SCP1, by proteomic screening of binding partners.
Kim YJ; Bahk YY
Biochem Biophys Res Commun; 2014 May; 448(2):189-94. PubMed ID: 24769477
[TBL] [Abstract][Full Text] [Related]
7. Structural and functional analysis of the phosphoryl transfer reaction mediated by the human small C-terminal domain phosphatase, Scp1.
Zhang M; Liu J; Kim Y; Dixon JE; Pfaff SL; Gill GN; Noel JP; Zhang Y
Protein Sci; 2010 May; 19(5):974-86. PubMed ID: 20222012
[TBL] [Abstract][Full Text] [Related]
8. USP49 negatively regulates tumorigenesis and chemoresistance through FKBP51-AKT signaling.
Luo K; Li Y; Yin Y; Li L; Wu C; Chen Y; Nowsheen S; Hu Q; Zhang L; Lou Z; Yuan J
EMBO J; 2017 May; 36(10):1434-1446. PubMed ID: 28363942
[TBL] [Abstract][Full Text] [Related]
9. Development of a Substrate Identification Method for Human Scp1 Phosphatase Using Phosphorylation Mimic Phage Display.
Otsubo K; Yoneda T; Kaneko A; Yagi S; Furukawa K; Chuman Y
Protein Pept Lett; 2018; 25(1):76-83. PubMed ID: 29210629
[TBL] [Abstract][Full Text] [Related]
10. Scribble-mediated membrane targeting of PHLPP1 is required for its negative regulation of Akt.
Li X; Yang H; Liu J; Schmidt MD; Gao T
EMBO Rep; 2011 Jun; 12(8):818-24. PubMed ID: 21701506
[TBL] [Abstract][Full Text] [Related]
11. MIIP inhibits the growth of prostate cancer via interaction with PP1α and negative modulation of AKT signaling.
Yan G; Ru Y; Yan F; Xiong X; Hu W; Pan T; Sun J; Zhang C; Wang Q; Li X
Cell Commun Signal; 2019 May; 17(1):44. PubMed ID: 31092266
[TBL] [Abstract][Full Text] [Related]
12. Arabidopsis SCP1-like small phosphatases differentially dephosphorylate RNA polymerase II C-terminal domain.
Feng Y; Kang JS; Kim S; Yun DJ; Lee SY; Bahk JD; Koiwa H
Biochem Biophys Res Commun; 2010 Jun; 397(2):355-60. PubMed ID: 20513350
[TBL] [Abstract][Full Text] [Related]
13. Suppression of BMP-Smad signaling axis-induced osteoblastic differentiation by small C-terminal domain phosphatase 1, a Smad phosphatase.
Kokabu S; Ohte S; Sasanuma H; Shin M; Yoneyama K; Murata E; Kanomata K; Nojima J; Ono Y; Yoda T; Fukuda T; Katagiri T
Mol Endocrinol; 2011 Mar; 25(3):474-81. PubMed ID: 21239611
[TBL] [Abstract][Full Text] [Related]
14. Dephosphorylation of the linker regions of Smad1 and Smad2/3 by small C-terminal domain phosphatases has distinct outcomes for bone morphogenetic protein and transforming growth factor-beta pathways.
Sapkota G; Knockaert M; Alarcón C; Montalvo E; Brivanlou AH; Massagué J
J Biol Chem; 2006 Dec; 281(52):40412-9. PubMed ID: 17085434
[TBL] [Abstract][Full Text] [Related]
15. A novel RNA polymerase II C-terminal domain phosphatase that preferentially dephosphorylates serine 5.
Yeo M; Lin PS; Dahmus ME; Gill GN
J Biol Chem; 2003 Jul; 278(28):26078-85. PubMed ID: 12721286
[TBL] [Abstract][Full Text] [Related]
16. DUSP5 promotes osteogenic differentiation through SCP1/2-dependent phosphorylation of SMAD1.
Liu X; Liu X; Du Y; Hu M; Tian Y; Li Z; Lv L; Zhang X; Liu Y; Zhou Y; Zhang P
Stem Cells; 2021 Oct; 39(10):1395-1409. PubMed ID: 34169608
[TBL] [Abstract][Full Text] [Related]
17. Vitamin E facilitates the inactivation of the kinase Akt by the phosphatase PHLPP1.
Huang PH; Chuang HC; Chou CC; Wang H; Lee SL; Yang HC; Chiu HC; Kapuriya N; Wang D; Kulp SK; Chen CS
Sci Signal; 2013 Mar; 6(267):ra19. PubMed ID: 23512990
[TBL] [Abstract][Full Text] [Related]
18. The diverse roles of RNA polymerase II C-terminal domain phosphatase SCP1.
R HR; Kim H; Noh K; Kim YJ
BMB Rep; 2014 Apr; 47(4):192-6. PubMed ID: 24755554
[TBL] [Abstract][Full Text] [Related]
19. Protein serine/threonine phosphatase-1 dephosphorylates p53 at Ser-15 and Ser-37 to modulate its transcriptional and apoptotic activities.
Li DW; Liu JP; Schmid PC; Schlosser R; Feng H; Liu WB; Yan Q; Gong L; Sun SM; Deng M; Liu Y
Oncogene; 2006 May; 25(21):3006-22. PubMed ID: 16501611
[TBL] [Abstract][Full Text] [Related]
20. Both decreased and increased SRPK1 levels promote cancer by interfering with PHLPP-mediated dephosphorylation of Akt.
Wang P; Zhou Z; Hu A; Ponte de Albuquerque C; Zhou Y; Hong L; Sierecki E; Ajiro M; Kruhlak M; Harris C; Guan KL; Zheng ZM; Newton AC; Sun P; Zhou H; Fu XD
Mol Cell; 2014 May; 54(3):378-91. PubMed ID: 24703948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
